financetom
Business
financetom
/
Business
/
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
Feb 14, 2025 10:37 AM

Feb 14 (Reuters) -

Zoetis ( ZTS ) said on Friday its bird flu vaccine has

received the U.S. Department of Agriculture's conditional

license for use in poultry.

A conditional license is used to meet an emergency

condition, limited market, or other special circumstance and is

issued for a finite period of time.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AXA IM Prime takes 20% stake in French private credit firm Rivage
AXA IM Prime takes 20% stake in French private credit firm Rivage
Jul 30, 2024
July 30 (Reuters) - AXA IM Prime, a unit of AXA Investment Managers, will acquire a 20% stake in French private credit firm Rivage Investment, the two companies said in a joint statement on Tuesday. Separately, AXA IM Prime, a long-standing investor in Rivage's strategies, will also put money in some of its infrastructure debt strategies, the companies said. Rivage...
Terns Pharmaceuticals Names Elona Kogan as Chief Legal Officer; CFO Mark Vignola to Leave in 'Planned Transition'
Terns Pharmaceuticals Names Elona Kogan as Chief Legal Officer; CFO Mark Vignola to Leave in 'Planned Transition'
Jul 30, 2024
04:45 AM EDT, 07/30/2024 (MT Newswires) -- Terns Pharmaceuticals ( TERN ) said late Monday that it appointed Elona Kogan as its chief legal officer while announcing changes to its c-suite. Kogan, who takes over with immediate effect, joins the company with a career spanning over 20 years in the life sciences sector. Previously, she served as the chief legal...
Telefonica Brasil Q2 Earnings, Revenue Rise
Telefonica Brasil Q2 Earnings, Revenue Rise
Jul 30, 2024
04:50 AM EDT, 07/30/2024 (MT Newswires) -- Telefonica Brasil ( VIV ) reported late Monday Q2 earnings of 0.74 Brazilian reais ($0.13) per share, up from 0.68 reais a year earlier. A single analyst polled by Capital IQ expected 0.86 reais. Revenue for the quarter was 13.68 billion reais, up from 12.73 billion reais a year earlier. Analysts polled by...
Verastem Gets FDA Orphan Drug Designation for Avutometinib With Defactinib to Treat Pancreatic Cancer
Verastem Gets FDA Orphan Drug Designation for Avutometinib With Defactinib to Treat Pancreatic Cancer
Jul 30, 2024
05:02 AM EDT, 07/30/2024 (MT Newswires) -- Verastem ( VSTM ) said Monday that the US Food and Drug Administration has granted orphan drug designation to avutometinib in combination with defactinib for the potential treatment of pancreatic cancer. This comes after the company reported positive initial interim results from the ongoing RAMP 205 trial evaluating avutometinib and defactinib in combination...
Copyright 2023-2026 - www.financetom.com All Rights Reserved